Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsTransplantation ConditioningHematopoietic Stem CellsBlood BanksGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Bone Marrow TransplantationMelphalanGraft SurvivalGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyTreatment OutcomeTransplantation ChimeraCell DifferentiationBusulfanMyeloablative AgonistsMultiple MyelomaTissue DonorsCyclophosphamideBlood Component RemovalRecurrenceMice, SCIDAntineoplastic Combined Chemotherapy ProtocolsRemission InductionHistocompatibility TestingCells, CulturedHistocompatibilityLiver TransplantationWhole-Body IrradiationLeukemiaLymphoma, Non-HodgkinImmunosuppressive AgentsAntineoplastic Agents, AlkylatingRetrospective StudiesMesenchymal Stem Cell TransplantationVidarabineDisease-Free SurvivalHematopoiesisGraft vs Leukemia EffectEtoposideInfectionThiotepaSurvival RateTime FactorsTransplantation, IsogeneicSurvival AnalysisSalvage TherapyCell TransplantationLeukemia, Myeloid, AcuteKidney TransplantationHematologic DiseasesEmbryonic Stem CellsPOEMS SyndromeAmyloidosisHodgkin DiseaseBlood CellsSpinal CordLymphomaMyelodysplastic SyndromesAdult Stem CellsCytarabineHLA AntigensVincristineAnemia, AplasticCytomegalovirus InfectionsFollow-Up StudiesMice, Inbred NODLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFatal OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyCarmustineLymphocyte DepletionImmunosuppressionIfosfamideT-LymphocytesPlatelet CountBone Marrow CellsCyclosporineBone MarrowPluripotent Stem CellsHeart TransplantationImmunophenotypingLymphocytesLymphocyte TransfusionBlood DonorsBlood Cell CountGraft vs Tumor Effect